Switch to:
More From Other Websites
The Factors behind Gilead’s Discounted Valuation Sep 23 2016
Allergan's Vitae Buy Could Spark More Interest in Kadmon Sep 23 2016
HC Wainwright Initiates OncoMed Pharmaceuticals With Buy Rating, $20 Target Sep 22 2016
3 Health Stocks to Own for the Next 10 Years Sep 22 2016
Celgene Presents Efficacy & Safety Phase II Ozanimod Data Sep 20 2016
How To Predict The Next Sarepta (FDA Approval Stock) And Win Big Sep 19 2016
RBC Says These 4 Top Biotechs Could Have Big Upside Potential Sep 19 2016
Vertex: Did Management Deliver Investors a Backhanded Slap? Sep 16 2016
Oral Ozanimod Efficacy and Safety Results at 2 Years from Phase 2 RADIANCE Trial of Patients with... Sep 16 2016
Oral Ozanimod Efficacy and Safety Results at 2 Years from Phase 2 RADIANCE Trial of Patients with... Sep 16 2016
Celgene Outspends Big Pharmas in Deals (CELG) Sep 15 2016
Celgene’s Big Bet May Pay Off (CELG) Sep 15 2016
Biotechs Help Nasdaq To Small Gain; Apple's Rise Fails To Spur Dow Sep 14 2016
Celgene's Crohn's Disease Drug Positive in Phase Ib Study Sep 13 2016
First-Ever Psoriatic Arthritis Awareness Day Aims to Educate on Importance of Early Diagnosis and... Sep 13 2016
First-Ever Psoriatic Arthritis Awareness Day Aims to Educate on Importance of Early Diagnosis and... Sep 13 2016
Short Sellers Run for Cover From Major Biotechs Sep 13 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK